BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//http://www.ucmr.umu.se//NONSGML kigkonsult.se iCalcreator 2.29.29
 //
CALSCALE:GREGORIAN
METHOD:PUBLISH
UID:7284b3af-fa5f-4f4b-ae00-9eeae1e5031e
X-WR-CALNAME:JCal Pro Calendar
X-WR-CALDESC:Your online events calendar
X-WR-TIMEZONE:Europe/Stockholm
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:STANDARD
TZNAME:CET
DTSTART:20251026T030000
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
RDATE:20261025T030000
RDATE:20271031T030000
END:STANDARD
BEGIN:DAYLIGHT
TZNAME:CEST
DTSTART:20260329T020000
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
RDATE:20270328T020000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
UID:4cc06f27169087fd82d61068b7a32876http://www.ucmr.umu.se
DTSTAMP:20260705T030913Z
CATEGORIES:General
DESCRIPTION:Thesis Defence <br />Jim Silver <br />Clinical Microbiology <br
  /><br />Title: <br />Replication-competent adenovirus 11p vector as a new
  anticancer agent <br /><br />Opponent: Senior lecturer Gunnel Halldén\, B
 arts Cancer Institute\, Queen Mary University\, UK.  <br /><br />Superviso
 r: Ya-Fang Mei\, Clinical Microbiology\, Virology<br /><br />Place: Biomed
 icinhuset\, Astrid Fagraeus-salen (A103)\, NUS
DTSTART;TZID=Europe/Stockholm:20120120T090000
DTEND;TZID=Europe/Stockholm:20120120T100000
SUMMARY:Thesis Defence: Jim Silver: Replication-competent adenovirus 11p ve
 ctor as a new anticancer agent
URL:http://www.ucmr.umu.se/about-ucmr/events/162-ucmr-calendar/165-general/
 164-thesis-defence-jim-silver-replication-competent-adenovirus-11p-vector-
 as-a-new-anticancer-agent.html
X-ALT-DESC;FMTTYPE=TEXT/HTML:Thesis Defence <br />Jim Silver <br />Clinical
  Microbiology <br /><br />Title: <br />Replication-competent adenovirus 11
 p vector as a new anticancer agent <br /><br />Opponent: Senior lecturer G
 unnel Halldén\, Barts Cancer Institute\, Queen Mary University\, UK.  <br 
 /><br />Supervisor: Ya-Fang Mei\, Clinical Microbiology\, Virology<br /><b
 r />Place: Biomedicinhuset\, Astrid Fagraeus-salen (A103)\, NUS
END:VEVENT
END:VCALENDAR
